Viking Therapeutics, Inc. (VKTX): 424B5 filed Sep 25, 2026

Form type
424B5
Filing date
Sep 25, 2026
Accession number
0001193125-26-401384
Filer
Viking Therapeutics, Inc. (CIK 1607678)